Literature DB >> 19639174

Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.

C M Haaland1, C M Heaphy, K S Butler, E G Fischer, J K Griffith, M Bisoffi.   

Abstract

Field cancerization denotes the occurrence of aberrant cells in tumor adjacent histologically normal tissues (TAHN). To characterize field cancerization in prostate cancer, we used RNA from paired patient tumor and TAHN tissues excised at 1 cm from the tumor margin and subjected them to microarray expression analysis comparative to RNA from normal cancer-free prostatic tissues. Eleven novel transcripts were significantly up-regulated in TAHN tissues and also in tumors. Expression of early growth response protein 1, tristetraprolin, testican, and fatty acid synthase, mutually up-regulated at different levels in tumors and TAHN tissues was confirmed by quantitative reverse transcriptase PCR in the experimental and in an independent validation set. This study offers proof of expressional changes in field cancerized prostatic TAHN tissues at defined distances from tumor margins. Markers of field cancerized prostatic tissues could be early diagnostic indicators in biopsies after abnormal prostate-specific antigen and digital rectal examination and independent of cancerous histology and/or early targets for chemo-preventive intervention in pre-malignant disease.

Entities:  

Mesh:

Year:  2009        PMID: 19639174     DOI: 10.3892/ijo_00000365

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  24 in total

1.  Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.

Authors:  Farhad Kosari; John C Cheville; Cristiane M Ida; R Jeffrey Karnes; Alexey A Leontovich; Thomas J Sebo; Sibel Erdogan; Erika Rodriguez; Stephen J Murphy; George Vasmatzis
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

2.  ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Authors:  Anna Vinarskaja; Wolfgang Goering; Marc Ingenwerth; Wolfgang A Schulz
Journal:  World J Urol       Date:  2011-09-01       Impact factor: 4.226

3.  Organ-wide telomeric status in diseased and disease-free prostatic tissues.

Authors:  Christopher M Heaphy; Trisha M Fleet; Eric G Treat; Sang-Joon Lee; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith; Edgar G Fischer; Marco Bisoffi
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

4.  Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.

Authors:  Anna C Jones; Kristina A Trujillo; Genevieve K Phillips; Trisha M Fleet; Jaclyn K Murton; Virginia Severns; Satyan K Shah; Michael S Davis; Anthony Y Smith; Jeffrey K Griffith; Edgar G Fischer; Marco Bisoffi
Journal:  Prostate       Date:  2011-11-29       Impact factor: 4.104

5.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

Review 6.  Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Authors:  Jennifer A Byrne; Sarah Frost; Yuyan Chen; Robert K Bright
Journal:  Tumour Biol       Date:  2014-05-06

7.  Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient Population.

Authors:  Lorena Legisi; Elise DeSa; M Nasar Qureshi
Journal:  Am Health Drug Benefits       Date:  2016-12

Review 8.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

9.  Current prostate biopsy protocols cannot reliably identify patients for focal therapy: correlation of low-risk prostate cancer on biopsy with radical prostatectomy findings.

Authors:  Philip Quann; David F Jarrard; Wei Huang
Journal:  Int J Clin Exp Pathol       Date:  2010-03-30

10.  Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation.

Authors:  Pinar O Eser; John P Vanden Heuvel; John Araujo; Jerry T Thompson
Journal:  Mol Clin Oncol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.